Long-term follow-up of mitral valve repair: a single-center experience

Ghada M M Shahin1, Geert J M G van der Heijden, Johannes C Kelder

  • 1Department of Cardio-thoracic Surgery and Cardiology, Sint Antonius Hospital Nieuwegein, and Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands. g.m.m.shahin@isala.nl

Insights

Long-term follow-up after mitral valve repair shows higher than expected mortality. Key predictors for death include coronary artery bypass grafting, kidney problems, older age, and reduced heart function.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Clinical Outcomes Research

Background:

  • Mitral valve regurgitation is a common condition requiring surgical intervention.
  • Long-term outcomes after mitral valve repair are crucial for patient management.
  • Assessing mortality determinants post-mitral valve repair is essential for improving survival rates.

Purpose of the Study:

  • To perform a long-term follow-up of patients undergoing mitral valve repair for regurgitation.
  • To identify independent predictors of mortality after this procedure.
  • To compare observed mortality rates with standardized mortality in the general population.

Main Methods:

  • Retrospective analysis of 119 patients operated between 1976 and 1981.
  • Exclusion of patients with prior mitral surgery, isolated stenosis, or congenital heart disease.
  • Kaplan-Meier survival analysis and multivariate analysis to identify mortality predictors, with up to 27 years of follow-up.

Main Results:

  • The 20-year overall mortality was 63%, significantly exceeding the standardized mortality rate of 30%.
  • Independent predictors for mortality included concomitant coronary artery bypass grafting, renal impairment, age over 60, and ejection fraction ≤40%.
  • Re-operation was necessary in 22.7% of cases.

Conclusions:

  • Mitral valve repair for regurgitation is associated with higher-than-expected long-term mortality.
  • Concomitant coronary artery bypass grafting, renal impairment, advanced age, and reduced left ventricular function are critical mortality predictors.
  • These findings highlight the need for careful patient selection and risk stratification.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...